What is the effect of latent genital tuberculosis (GTB) on ovarian reserve in infertile women?
Introduction
Tuberculosis (TB), an infectious disease caused by Mycobacterium TB (M TB), is a major health issue of global importance. Six countries including India and China account for 60% of global TB burden (WHO Global Tuberculosis Report, 2017) and the incidence of TB is increasing even in low burden countries (Nezar et al., 2009; Türkmen et al., 2012) . Genital TB (GTB) is a common form of extrapulmonary TB secondary to haematogenous spread of the bacteria and is an important cause of infertility in women (Gupta et al., 2007; Türkman et al., 2012) . The Fallopian tubes are the most commonly affected site, followed by the endometrium and ovaries (Sharma, 2008) . Infertility may be the only symptom in majority of the women with latent GTB (Dam et al., 2006; Jindal, 2006; Jindal et al., 2012; Index TB Guidelines, 2016) .
GTB is paucibacillary in nature, with a low detection rate (7-19%) when the common diagnostic modalities of microbiological culture, histopathology and laparoscopy are used in infertile women with clinical suspicion (Bhanu et al., 2005; Jindal, 2006; Bhanothu et al., 2014; Index TB Guidelines, 2016) . In addition, an important feature of latent TB is loss of culturability (Gangadharam, 1995; Salina et al., 2009) . Both factors may contribute to the reported discordance in the detection rate between bacteriological culture and DNA PCR (Bhanu et al., 2005; Mahajan et al., 2016) . DNA PCR is increasingly used for diagnosing GTB in asymptomatic infertile women with a high index of clinical suspicion (Nezar et al., 2009; Index TB Guidelines, 2016) , as it has high sensitivity (57-87%) and specificity (90-100%), particularly when multi-gene amplification is performed (Jindal et al., 2010; Thangappah et al., 2011; Bhanothu et al., 2014) .
Latent GTB refers to the presence of M TB in the genital tract, identified by DNA PCR without laparoscopic, microbiological or histopathological evidence and is diagnosed in 35-50% of infertile women in India (Bhanu et al., 2005; Jindal et al., 2010; Rana et al., 2011; Kulshrestha et al., 2011; Sankar et al., 2013; Bhanothu et al., 2014) .
Tuberculous damage to tubal function and the endometrium in histologically confirmed GTB is well documented (Sharma et al., 2008; Banerjee et al., 2012) . Limited evidence suggests that GTB may also affect ovarian reserve adversely (Gurgan et al., 1996; Malhotra et al., 2012) . However whether latent GTB has any effect on ovarian function is unknown.
Anti-Mullerian hormone (AMH) is produced by the granulosa cells of growing follicles in ovary (Weenen et al., 2004; Modi et al., 2006) . Its concentration in serum reflects the number of antral follicles in ovaries estimated by transvaginal ultrasonography (TVS) (Nardo et al., 2007; Broer et al., 2009) . AMH and antral follicle count (AFC) are considered as the most sensitive markers of ovarian reserve (van Rooij et al., 2002; Nelson et al., 2009 Nelson et al., , 2015a Jayaprakasan et al., 2010; Broer et al., 2013) . Both exhibit a positive correlation to oocyte yield in IVF programs utilizing conventional protocols (Majumder et al., 2010; Nelson et al., 2015b) .
In the present study, we aimed to determine the effects of latent GTB on ovarian reserve in a large cohort of infertile women by employing robust markers of ovarian reserve such as AMH, AFC and oocyte yield.
Materials and Methods

Study design and population
This prospective cohort study was performed at a private tertiary referral centre for infertility: Shreyas Hospital, Kolhapur, India, between February 2013 and January 2016. All participants provided written informed consent.
Inclusion criteria
Eumenorrhoic and oligomenorrhoic normogonadotropic women, of 21-38 years of age and with primary or secondary infertility of more than 2 years duration, were included in the study. They had received at least six documented cycles of ovulation induction elsewhere, with or without additional treatment of intrauterine insemination (IUI) or IVF. Tubal patency was diagnosed by laparoscopy performed elsewhere within the past two years or during the course of treatment in our centre, with a documented absence of visible tubal pathology. Diagnosis of PCOS was based on Rotterdam criteria (ASRM/ESHRE consensus 2004).
Exclusion criteria
Women with a prior history of TB or treatment for TB, proven tubal infertility, previous ectopic pregnancy, ovarian surgery, premature ovarian failure or severe male factor infertility (total motile sperm concentration of <5 million) were excluded.
Investigations
Age, duration of infertility, area of residence (urban/rural), menstrual cycle length, menstrual flow, body mass index (BMI), previous treatment history and previous miscarriages were documented.
Participants who met the inclusion criteria underwent TVS on Day 2-4 of a cycle prior to endometrial biopsy, to rule out pelvic pathology and for measurement of AFC, as described previously (Broekmans et al., 2010) . AFC was measured by a single operator (PRJ) using an Aloka scanner (model SSD -4000 Plus; Hitachi Aloka Medical, Japan). Follicles with diameter of 2-6 mm in both ovaries were counted in the AFC.
A cycle Day 2-4 hormone profile including serum follicular stimulating hormone (FSH), leutinizing hormone (LH) and AMH was performed at Ambika Laboratory, an external quality assurance services (EQUAS) certified laboratory in Kolhapur. Serum FSH and LH were measured using automated electrochemiluminiscence assays (Roche Diagnostics e411, Boehringer Mannheim, Germany), while 2 ml of blood was collected from the subjects and serum was frozen at −40°C for the AMH assay. AMH was measured in batches with Gen II enzyme-linked immunosorbent assay (Beckman Coulter Inc., USA). The inter-assay co-efficient of variation for AMH was 3.8-11.0% and the intra-assay co-efficient of variation was 5.1-10.1%.
Endometrial biopsy was performed at the time of laparoscopy or as an outpatient procedure using a sterile disposable aspiration cannula. The tissue was transported in a sterile container with normal saline, for a real time multiplex DNA PCR (RT PCR) for M TB to Super Religare Laboratories Ranbaxy Limited, Mumbai, India, a laboratory certified by the College of American Pathologists (CAP) and the National Accreditation Board for Laboratories (NABL) for the scope of this investigation.
Based on the results of RT PCR, the subjects were divided into Group I, consisting of women with an endometrial biopsy showing the presence of M TB, and Group II, consisting of women negative for latent GTB by PCR.
Follow-up and treatment
All women in Group I were evaluated by a pulmonologist (A.K. or S.K.). They were counselled and prescribed standard ATT. They received verbal and written information regarding the need for compliance and possible side effects and were asked to report in the event of experiencing any recognized side effects of ATT. They were followed up every 15 days for the first 2 months. Fertility treatment was initiated subsequently as governed by the clinical indication, while ensuring compliance with ATT. IVF, when deemed necessary, was performed after ATT completion. Women in Group II were advised to have treatment for infertility from the subsequent cycle.
Ovulation induction and assisted reproduction
Age, duration and aetiology of infertility, ovarian reserve and previous treatment guided further management. A short duration of ovulation induction and timed intercourse or up to two cycles of IUI or IVF/ICSI were advised as appropriate. Individualized ovarian stimulation protocols were used for IVF based on serum AMH values. Two embryologists, blinded to the PCR data, performed sequential morphological assessment of embryos. A maximum of two embryos were transferred on Days 3 or 5. Transfer of three embryos was considered in women who were above 35 years of age or poor ovarian responders or women with previous IVF failures. Both groups were followed up for 12 months after initiating active treatment for infertility. Those who conceived were followed up for further nine months to document the pregnancy outcome.
Outcome measures
Primary outcome measure was the impact of latent GTB on the ovarian reserve markers, AMH and AFC, and on oocyte yield in those who underwent IVF/ICSI. Secondary outcome measures were the pregnancy outcome following ATT and the treatment modalities required to achieve pregnancy.
Statistical analysis
Descriptive and inferential statistical analysis was performed. Shapiro-Wilk test was performed to assess for normal distribution and the nonparametric Mann-Whitney U test was performed for inter-group comparisons. Results are presented as median (interquartile range) or as mean ± SD. Multivariate analysis using MANOVA was applied to the entire data set, followed by ANOVA to identify the age-adjusted level of significance. Significance was assessed at 5% level of significance. The statistical software used was IBM SPSS 22.0.
Sample size estimation
For an outcome variable of AMH with a mean difference of 0.55 (SD = 3.0) for a two group clinical study with 90% statistical power at a 5% level of significance, a sample size of 750 was found to be adequate.
Ethical approval
The study was approved by the Institutional Review Board of Shreyas Hospital.
Results
A total of 2357 women visited our hospital with infertility during the study period. Of these, 884 women fulfilled the inclusion criteria and underwent endometrial sampling. Based on the results of RT PCR, 431 women (48.8%) were included in Group I and 453 women (51.2%) were included in Group II. Following exclusion for tubal damage noted during a subsequent laparoscopy or incomplete data or follow-up, the data available for 395 women in Group I and 383 in Group II, were analysed (Fig. 1) . These exclusions did not affect their treatment with standard ATT and/or their clinical care as per the institute norms.
Demographic details of all those who completed the study are summarized in Table I . Women in Group I were significantly younger than those in Group II. Other parameters did not show any inter-group difference.
Reduced ovarian reserve in women with latent GTB There was no difference in the serum FSH concentration between the two groups [median (IQR): 7.9 (6.2, 9.8) IU/l vs. 7.8 (6.2, 10.4) IU/l; P = 0.37]. However AMH [median (IQR): 2.0 (0.9, 4.1) ng/ml vs. 2.8 (1.3, 5) ng/ml; P < 0.001] and AFC [median (IQR): 7 (5, 11) vs. 8 (5, 14); P = 0.001] were significantly lower in Group I compared to Group II (Fig. 2) . The magnitude of reduction was 15% for both markers. These differences remained after adjustment for age.
In those undergoing IVF, a significantly lower oocyte yield was noted in Group I (n = 137) compared to Group II (n = 142). Though the number of embryos transferred was lower in Group I, the number of Grade I embryos transferred and the implantation rate were significantly higher compared to Group II (Table II) . 
Subgroup analysis
Since PCOS bis a confounding factor for AMH and AFC in prediction of ovarian reserve, we further analysed the data by excluding women with PCOS. The women in Group I were significantly younger than women in Group II [median (IQR): 30 (27, 34) years vs. 32 (28, 35); P = 0.02] and had significantly lower AMH [median (IQR): 1.6 (0.7, 2.6) ng/ml vs 2.3 (1.2, 4.0) ng/ml; P < 0.001] and AFC [median (IQR): 6 (4, 9) vs 7 (5, 11); P < 0.001] than those in Group II (Figure 2 ). Women in Group I yielded fewer total and MII oocytes while undergoing IVF and had significantly fewer embryos were transferred. However, they had a significantly greater number of Grade I embryos and a higher implantation rate compared to Group II (Table II) .
Pregnancy outcomes
Despite short duration of ovulation induction, a significantly higher number of clinical pregnancies were achieved with simple treatment modalities in Group I compared to Group II, obviating the need for IVF in~25% of the women. The Group I women also achieved more pregnancies in IVF compared to the Group II women (Table III) . In total, 188 and 139 women conceived with their own oocytes in Groups I and II, respectively. Among those who conceived, women in Group I had significantly lower AMH compared to women Group II (P < 0.001). Within both groups, those who conceived had higher AMH compared to those who did not; however this difference was not noted in Group I after excluding women with PCOS (Table IV) .
Discussion
To our knowledge, this is the first sufficiently powered study, evaluating an association between latent GTB and markers of ovarian reserve and ovarian response. Our study shows that in women with prolonged infertility, GTB may exist in a latent form affecting the ovarian reserve despite their young age.
Inclusion of women with multiple treatment failures and prolonged infertility, the study setting of a tertiary clinic and the use of RT PCR, all contribute to the high prevalence of latent GTB noted in the present study. These findings concur with previous reports from India (Bhanu et al., 2005; Rana et al., 2011; Kulshrestha et al., 2011; Jindal et al., 2012; Sankar et al., 2013) .
AMH and AFC are considered the two most sensitive markers of ovarian reserve and of response after stimulation (Nelson et al., 2009 (Nelson et al., , 2015a Jayaprakasan et al., 2010; Broer et al., 2013) . In the present study, we observed that infertile women with latent GTB have significantly lower AMH and AFC compared to the uninfected group suggesting a compromised ovarian reserve. Clinical observations have clearly demonstrated a diminishing ovarian reserve with advancing age Nelson et al., 2012) . However, we observed that the lower AMH and AFC in women with latent GTB were not age related, as these women were significantly younger compared to uninfected women. This strongly suggests that the presence of M TB in the genital tract compromises ovarian follicle pool leading to an advanced ovarian age.
It is well documented that women with PCOS have high AMH and AFC (Pigny et al., 2003; Broer et al., 2011; Dewailly et al., 2011) . This may mask an abnormal decrease in ovarian reserve in the cohort. Indeed, the results of our study show that the magnitude of decline in ovarian reserve was greater following exclusion of women with PCOS, revealing a 33% lower serum AMH and 20% lower AFC in women with latent GTB, compared to those without latent GTB. These observations, coupled with the fact that women with latent GTB were younger, suggest that the magnitude of decline in ovarian reserve could be quite high. Upon exclusion of subjects with PCOS, we observed that the number of total and MII oocytes was significantly lower in subjects with latent GTB compared to uninfected controls. It is known that both AMH and oocyte yield have a direct correlation and oocyte yield influences the occurrence of pregnancy in IVF (Nelson et al., 2007 (Nelson et al., , 2015a Majumder et al., 2010; Sunkara et al., 2011; Arce et al., 2013; Brodin et al., 2013) . Despite the lower ovarian reserve, it was interesting to note that embryo quality, implantation rate and pregnancy rate were higher in our study in women treated for latent GTB compared to the control group. This strongly suggests an improved ovarian microenvironment following ATT. However, the relative role of an improved uterine environment for a better implantation rate cannot be excluded as a contributory factor. The pregnancy outcome in our study supports the existing data of a favourable outcome following treatment of latent GTB Jindal et al., 2012) .
The mechanisms involved in the ovarian damage in latent GTB are unclear. It is generally believed that latent GTB is a dormant infection without any impact on the host's tissue. Recent studies of both Values are expressed as mean ± SD or as numbers (%). *P = significant. pulmonary and lymph node TB, however, challenge this view. A virtual human model and animal models both show that latency is achieved when the host mounts an immune response through Th1 and Th2 lymphocytes to contain the infection without progression to active disease, but at the expense of tissue damage (Wigginton and Kirschner, 2001; Lin and Flynn, 2010 ). An immunohistochemical study of TB lymph nodes has shown down-regulation of the host microbicidal functions within the macrophages in TB granulomas and ongoing production of pro-inflammatory cytokines such as TNFa and interleukins including IL-10 ( Mustafa et al., 2006) . Mechanisms leading to metabolic plasticity and the ability of the bacteria to adapt to changing host immune responses resulting in latency have been reviewed recently (Mogombedze et al., 2013) . A lipid rich environment and nitiric oxide among other factors may make the ovaries a suitable organ for M TB to reside in the latent phase. Granulomas have been identified from 20% of ovarian biopsies of infertile women in a recent study (Bhanothu et al., 2014) . Impaired local immunity associated with infertility may also encourage latency. It is possible that similar to pulmonary TB, immune-mediated tissue damage leading to local fibrosis and vascular damage in the ovaries may result in adverse consequences. While ATT is considered as a standard therapy for active TB, there are concerns in treating an asymptomatic infection. Poor adherence to treatment and emergence of multidrug resistant TB (MDR TB) strains is a real concern. In our cohort, we could achieve 100% adherence by providing appropriate counselling and regular follow-up. There is a paradigm shift in the management of TB as it is increasingly acknowledged that the control of TB is difficult without addressing the huge reservoir of latent TB (Lin and Flynn, 2010; Mogombedze et al., 2013) . It is even recommended that it should be treated in those with reversible risk factors (Gupta, 2012) and latent GTB with infertility fits in with this description. We believe that standardizing the indications for investigation, and utilization of appropriate referral laboratory services, improve the diagnostic accuracy of latent GTB. A multidisciplinary approach for management and diligent treatment, while preventing emergence of MDR TB, may provide an opportunity to halt the abnormal rate of deterioration of ovarian reserve in such individuals. An early decline in ovarian reserve due to latent GTB in high burden countries may impose an increased need for oocyte donation in women undergoing IVF and may have wider implications to women's health than infertility.
In conclusion, we have utilized robust markers of ovarian reserve and demonstrated for the first time that latent GTB in women with long-standing infertility is associated with a low ovarian reserve. Its treatment appears to significantly improve the pregnancy outcome in such women. The findings of this study warrant further evaluation of possible mechanisms of ovarian injury in such women. Re-assessment of ovarian reserve markers following completion of treatment and study of ovarian tissue biopsied when it is considered ethical may shed light on some of the underlying mechanisms. 
